Article

Radiation Recall Dermatitis after Treatment with Paclitaxel and Cisplatin

Annals of Dermatology (Impact Factor: 0.95). 05/2012; 24(2):223-4. DOI: 10.5021/ad.2012.24.2.223
Source: PubMed
Download full-text

Full-text

Available from: Hyo Jin Lee, May 23, 2014
1 Follower
 · 
231 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: We report a case of radiation recall dermatitis caused by trastuzumab. A 55-year-old woman with metastatic breast cancer received palliative first-line trastuzumab/paclitaxel and a salvage partial mastectomy with lymph node dissection was subsequently performed. In spite of the palliative setting, the pathology report indicated that no residual carcinoma was present, and then she underwent locoregional radiotherapy to ensure a definitive response. After radiotherapy, she has maintained trastuzumab monotherapy. Nine days after the fifth cycle of trastuzumab monotherapy, dermatitis in previously irradiated skin developed, with fever. Radiation recall dermatitis triggered by trastuzumab is extremely rare. A high fever developed abruptly with a skin rash. This may be the first case of this sort to be reported.
    Breast Cancer 03/2013; DOI:10.1007/s12282-013-0462-6 · 1.51 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The origin of collagen autoimmune diseases is not fully understood. Some studies postulate a mechanism of molecular mimicry or heterologous immunity following viral infections triggering autoimmunity. Apart from infections, other exogenous factors such as visible light or X-rays have been reported to incite autoimmunity. We report a case of histologically and serologically confirmed subacute lupus erythematosus (SCLE) following radiotherapy for breast cancer. The close temporal and spatial correlation between radiotherapy and onset of SCLE in this patient suggests that an autoimmune reaction may have been triggered locally by functionally altering the immune system and breaking self-tolerance.
    Case Reports in Dermatology 08/2013; 5(2):232-6. DOI:10.1159/000354721
  • [Show abstract] [Hide abstract]
    ABSTRACT: Radiation recall dermatitis (RRD) is an acute skin toxicity caused by different anticancer or antibiotic drugs within a former completely healed irradiation field. Predictive factors for RRD are not known and its mechanisms are not completely understood. A case of RRD induced by docetaxel and successfully treated by an antioxidant ointment (Mapisal(®)) is presented here. Such an ointment might be useful not only in RRD therapy, but also in the treatment of high-grade dermatitis induced by radiotherapy and thus may contribute to the improvement of patients' quality of life and to the scheduled completion of cancer therapies.
    Strahlentherapie und Onkologie 03/2014; DOI:10.1007/s00066-014-0609-1 · 2.73 Impact Factor